Tag Archives: PReP

Report shows U.S. HIV research investment, progress; projects lasting impact from cuts

By on .

With the United States funding 70 percent of the world’s research and development of biomedical answers to HIV prevention, progress that has yielded the potential for immediate advances against the global epidemic is in danger of stalling, with lasting consequences, according to a report released at the International AIDS Society conference in Kuala Lumpur this […]

With study of injecting drug users, preventive HIV medicine demonstrates protective value to all at high risk

By on .

CDC releases updated Guidance for Pre-Exposure Prophylaxis for the Prevention of HIV Infection: PrEP for Injecting Drug Users, while questions on real-world impact remain With a five-year study in Bangkok showing that daily doses of antiretroviral medicine reduced risks of HIV infection among people who inject drugs by at least half, and more with the […]

IPrEx Findings Hold in Extension Study

By on .

Science Speaks is in Atlanta, Georgia this week and will be live-blogging from the 20th CROI — Conference on Retroviruses and Opportunistic Infections from Sunday to Wednesday, covering breaking developments from investigators on cure research, new antiretroviral agents, hepatitis, tuberculosis and treatment as prevention. ATLANTA, GA — Robert Grant from University of California at San […]

After VOICE trial, question remains: What were women telling researchers?

By on .

Science Speaks is in Atlanta, Georgia this week and will be live-blogging from the 20th CROI — Conference on Retroviruses and Opportunistic Infections from Sunday to Wednesday, covering breaking developments from investigators on cure research, new antiretroviral agents, hepatitis, tuberculosis and treatment as prevention. Perhaps at some point what the VOICE trial (Vaginal and Oral […]

Reports track current progress, pitfalls, funding and gaps of AIDS fight

By on .

On the eve of Secretary Hillary Clinton’s release of the first United States global AIDS response strategy, two reports released in recent days give a look not only of the progress so far, but of the shortfalls the new plan must address. Achieving the End, One Year and Counting, from AVAC, looks at the scientific […]

Blueprint: Use proven methods, research, determination to reach end of epidemic

By on .

Dr. Rochelle Walensky has been a member of the Cost-effectiveness of Preventing AIDS Complications (CEPAC) team since 1998. She is a member of the Office of AIDS Research Advisory Council at the National Institutes of Health and the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents.  Dr. Walensky has […]

ID Week: Biomedical prevention efforts must address range of challenges

By on .

San Diego, CA — At a symposium entitled “Challenges and Opportunities in HIV Prevention today at ID Week, Jean Marrazzo offered a summation of the pre-exposure phophylaxis (PrEP) research findings and highlighted some of the nuances and unanswered questions about disparate study results. She began by defining the now widely used term “biomedical prevention” as […]

Blueprint: Dr. Myron Cohen on treatment as prevention and other essential elements of a global AIDS plan

By on .

Dr. Myron S. Cohen is the architect and principal investigator of the multinational HPTN 052 trial, which demonstrated that antiretroviral treatment prevents the sexual transmission of HIV-1. This work was recognized by Science Magazine as the “Breakthrough of the Year” in 2011. His research focuses on the transmission and prevention of transmission of HIV, and […]

The largest agency in global health, spreading word of home-grown research, a look at the Global Health Initiative’s life — and afterlife, and more . . .

By on .

The U.S. Department of Defense and Global Health: It is the oldest agency in the United States, has a reach that extends effectively to all countries, is involved in health service delivery and health research, but is not budgeted as a global health agency, nor is global health considered its mission. All the same, the […]

Study links homophobia, discrimination to prevention, testing, treatment barriers and to attitudes on preventive antiretrovirals

By on .

In the global AIDS epidemic, it is the illustration of a vicious circle: People in situations that leave them the most vulnerable to getting HIV have the least access to protection. They have the highest prevalence of the virus that leads to AIDS. Then they have the least access to care. That may not be […]